Yaz 0.02 mg - 3 mg (ethinylestradiol 0,02 mg + drospirenon 3 mg tablet (or.) (I) + placebo tablet (or.) (II)) · CNK 2677425

Product information

Yaz 0.02 mg - 3 mg
6 x 28 (24 + 4)
ethinylestradiol 0,02 mg + drospirenon 3 mg tablet (or.) (I) + placebo tablet (or.) (II)
2677425
0 / 10
Locked

Product properties

57-63-6
G03AA12
Bayer
Film-coated tablet
BE321386
04057598001496
M2
Public
321386-03

Pharmacist Assessment

Commercialization officially ended — no stock

SAM has flagged this product as commercially stopped (reason: Commercial reasons) and no stock is available from wholesalers. Switching to an alternative is necessary.

Recommended alternative

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Active
- present

Commercial reasons

Alternative available
Available
Until 31/01/2026

Composition

5 ingredients

Substance Type Strength CAS
Active ingredient
0.02 mg
57-63-6
Active ingredient
3 mg
67392-87-4
Excipient
48.18 mg
Active ingredient
Excipient
52.1455 mg

Additional information

View on BCPI

Availability statistics

Commercialization stopped
333 days
3
0
01/02/2026